Literature DB >> 23300175

A low-grade B-cell lymphoma with prolymphocytic/paraimmunoblastic proliferation and IRF4 rearrangement.

Kengo Takeuchi, Seiji Sakata, Reimi Asaka, Naoko Tsuyama, Akito Dobashi, Masaaki Noguchi.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2013        PMID： 23300175      PMCID： PMC3659954          DOI： 10.3324/haematol.2012.076851

Source DB:  PubMed          Journal:  Haematologica        ISSN： 0390-6078            Impact factor:   9.941


× No keyword cloud information.
  9 in total

1.  Deregulation of MUM1/IRF4 by chromosomal translocation in multiple myeloma.

Authors:  S Iida; P H Rao; M Butler; P Corradini; M Boccadoro; B Klein; R S Chaganti; R Dalla-Favera
Journal:  Nat Genet       Date:  1997-10       Impact factor: 38.330

2.  A monoclonal antibody (MUM1p) detects expression of the MUM1/IRF4 protein in a subset of germinal center B cells, plasma cells, and activated T cells.

Authors:  B Falini; M Fizzotti; A Pucciarini; B Bigerna; T Marafioti; M Gambacorta; R Pacini; C Alunni; L Natali-Tanci; B Ugolini; C Sebastiani; G Cattoretti; S Pileri; R Dalla-Favera; H Stein
Journal:  Blood       Date:  2000-03-15       Impact factor: 22.113

Review 3.  Bcl-6 protein expression in normal and neoplastic lymphoid tissues.

Authors:  B Falini; M Fizzotti; S Pileri; A Liso; L Pasqualucci; L Flenghi
Journal:  Ann Oncol       Date:  1997       Impact factor: 32.976

4.  bcl-1 translocations are frequent in the paraimmunoblastic variant of small lymphocytic lymphoma.

Authors:  L E Grosso; P D Kelley
Journal:  Mod Pathol       Date:  1998-01       Impact factor: 7.842

5.  Translocations activating IRF4 identify a subtype of germinal center-derived B-cell lymphoma affecting predominantly children and young adults.

Authors:  Itziar Salaverria; Claudia Philipp; Ilske Oschlies; Christian W Kohler; Markus Kreuz; Monika Szczepanowski; Birgit Burkhardt; Heiko Trautmann; Stefan Gesk; Miroslaw Andrusiewicz; Hilmar Berger; Miriam Fey; Lana Harder; Dirk Hasenclever; Michael Hummel; Markus Loeffler; Friederike Mahn; Idoia Martin-Guerrero; Shoji Pellissery; Christiane Pott; Michael Pfreundschuh; Alfred Reiter; Julia Richter; Maciej Rosolowski; Carsten Schwaenen; Harald Stein; Lorenz Trümper; Swen Wessendorf; Rainer Spang; Ralf Küppers; Wolfram Klapper; Reiner Siebert
Journal:  Blood       Date:  2011-04-12       Impact factor: 22.113

6.  Nuclear overexpression of lymphoid-enhancer-binding factor 1 identifies chronic lymphocytic leukemia/small lymphocytic lymphoma in small B-cell lymphomas.

Authors:  Bevan Tandon; Loann Peterson; Juehua Gao; Beverly Nelson; Shuo Ma; Steven Rosen; Yi-Hua Chen
Journal:  Mod Pathol       Date:  2011-06-17       Impact factor: 7.842

7.  Paraimmunoblastic variant of small lymphocytic lymphoma/leukemia.

Authors:  W C Pugh; J T Manning; J J Butler
Journal:  Am J Surg Pathol       Date:  1988-12       Impact factor: 6.394

8.  Genetic characterization of the paraimmunoblastic variant of small lymphocytic lymphoma/chronic lymphocytic leukemia: A case report and review of the literature.

Authors:  Blanca Espinet; Itziar Larriba; Marta Salido; Lourdes Florensa; Soledad Woessner; Jordi Sans-Sabrafen; Carles Barranco; Sergi Serrano; Francesc Solé
Journal:  Hum Pathol       Date:  2002-11       Impact factor: 3.466

9.  Use of novel t(11;14) and t(14;18) dual-fusion fluorescence in situ hybridization probes in the differential diagnosis of lymphomas of small lymphocytes.

Authors:  J L Frater; E K Tsiftsakis; E D Hsi; J Pettay; R R Tubbs
Journal:  Diagn Mol Pathol       Date:  2001-12
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.